A trial of reduced intensity conditioning and transplantation of haplotype mismatched and KIR class I epitope-mismatched highly purified CD34 cells
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Alemtuzumab; Ciclosporin; Ciclosporin; Fludarabine; Melphalan; Mycophenolate mofetil; Mycophenolate mofetil; Sargramostim
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Multiple myeloma; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 27 Nov 2019 Biomarkers information updated
- 30 Jul 2007 Status change from recruiting to completed
- 22 Oct 2005 New trial record.